Gene By Gene
Healthcare Software · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1445 North Loop W Ste 820, Houston, Texa...Website
www.genomx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Gene By Gene
GenomX offers a Clinical Reporting Application designed to streamline the complex and error-prone process of clinical reports management. By integrating analysis data with electronic lab ordering and results distribution, it provides healthcare providers and clinicians with a comprehensive solution to enhance productivity and reduce costs. The platform ensures data security through HIPAA-compliant cloud storage and features customizable reports and user-friendly dashboards. GenomX aims to facilitate efficient sharing of patient lab reports among multiple clinicians, making it a valuable tool for modern healthcare practices.Explore more
Gene By Gene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gene By Gene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Gene By Gene launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Gene By Gene has new funding data
Earning: See what the market has to say on Gene By Gene recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Gene By Gene
Check if Gene By Gene has recently received funding, and reach out quickly before it becomes old news!
Click to see if Gene By Gene had a recent Job posting/layoffs
Check out if Gene By Gene is spiking on competitors!
Gene By Gene, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Gene By Gene as Masked Content
Find 2 more new buyers
Compare Similar Companies to Gene By Gene
Compare insights from companies similar to Gene By Gene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gene By Gene is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Gene By Gene is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Gene By Gene.
Gene By Gene financials insights
Gather financial insights about Gene By Gene, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
Gene By Gene Tech Stack
A closer look at the technologies used by Gene By Gene
Most Recent Scoops
Promotion
Executive Move
Open Position
Funding
Gene By Gene has received an SBA PPP loan for $2-5 million from Zions Bank.
Funding
Gene By Gene News & Media
EasyDNA expands Indian and European markets; launching NIPT, Carrier testing and DNA storage
MELBOURNE, Australia, July 05, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce the Company’s recently acquired, EasyDNA, has embarked on a significant expansion in both its test portfolio and geographical reach.GeneType Risk Assessment Test onboarding in 16 clinics
MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce the Company has commenced initial implementation of its geneType Risk Assessment Test at 16 medical practices across the East Coast of Australia.Transformational Pathway to US Payer System; Attributing US$1.4 Billion Health and Economic Benefit from geneType Breast Cancer Risk Assessment Test
MELBOURNE, Australia, June 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease is delighted to announce the completion of an independently developed and validated customizable Budget Impact Model (BIM), which demonstrates significant health and economic benefits directly attributed to the implementation of geneType Breast Cancer Risk Assessment Test.Acquisition of global direct to consumer ecommerce business | News | bakersfield.com
MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease advises
Read more news
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gene By Gene
Sign Up For FreeTo access detailed company insights
GenomX offers a Clinical Reporting Application designed to streamline the complex and error-prone process of clinical reports management. By integrating analysis data with electronic lab ordering and results distribution, it provides healthcare providers and clinicians with a comprehensive solution to enhance productivity and reduce costs. The plat... Read More
